Skip to main content
. 2020 Mar 12;9(10):3268–3277. doi: 10.1002/cam4.2963

Table 2.

Univariable cox proportional hazards analysis for overall survival of gastric cancer patients before and after propensity score matching

Characteristics Before matching n = 1034 After matching n = 573
Statistics HR (95% CI) P value Statistics HR (95% CI) P value
Age, years, mean (SD) 61.72 ± 11.20 1.01 (1.00, 1.01) .121 61.78 ± 10.86 1.01 (1.00, 1.02) .013
Gender
Male 789 (76.31%) 1.00 (Ref.) 429 (74.87%) 1.00 (Ref.)
Female 245 (23.69%) 1.11 (0.92, 1.33) .279 144 (25.13%) 1.10 (0.88, 1.38) .401
Tumor size, cm, mean (SD) 5.92 ± 3.42 1.10 (1.08, 1.12) <.001 6.18 ± 3.60 1.08 (1.06, 1.11) <.001
Tumor location
Upper 297 (28.72%) 1.00 (Ref.) 165 (28.80%) 1.00 (Ref.)
Middle 184 (17.79%) 1.25 (0.99, 1.58) .066 102 (17.80%) 1.03 (0.76, 1.39) .854
Lower 434 (41.97%) 0.98 (0.80, 1.20) .845 239 (41.71%) 0.89 (0.69, 1.14) .358
Two regions or Entire 119 (11.51%) 2.64 (2.06, 3.38) <.001 67 (11.69%) 2.00 (1.45, 2.75) <.001
Surgical method
Open surgery 393 (38.01%) 1.00 (Ref.) 151 (26.35%) 1.00 (Ref.)
Laparoscopic surgery 641 (61.99%) 1.23 (1.04, 1.45) .014 422 (73.65%) 0.79 (0.63, 0.99) .037
Gastrectomy
Proximal 281 (27.18%) 1.00 (Ref.) 148 (25.83%) 1.00 (Ref.)
Distal 419 (40.52%) 1.15 (0.93, 1.41) .193 232 (40.49%) 1.14 (0.88, 1.49) .324
Total 334 (32.30%) 1.75 (1.42, 2.15) <.001 193 (33.68%) 1.51 (1.16, 1.96) .002
Lymphovascular invasion
Negative 724 (70.02%) 1.00 (Ref.) 397 (69.28%) 1.00 (Ref.)
Positive 310 (29.98%) 2.06 (1.75, 2.42) <.001 176 (30.72%) 2.01 (1.63, 2.48) <.001
Perineural invasion
Negative 766 (74.08%) 1.00 (Ref.) 437 (76.27%) 1.00 (Ref.)
Positive 268 (25.92%) 1.41 (1.19, 1.67) <.001 136 (23.73%) 1.45 (1.16, 1.82) .001
Histologic grade
Differentiated 432 (41.78%) 1.00 (Ref.) 229 (39.97%) 1.00 (Ref.)
Undifferentiated 602 (58.22%) 1.56 (1.33, 1.84) <.001 344 (60.03%) 1.53 (1.24, 1.89) <.001
Depth of invasion
T1 64 (6.19%) 1.00 (Ref.) 17 (2.97%) 1.00 (Ref.)
T2 114 (11.03%) 1.86 (1.01, 3.43) .047 38 (6.63%) 1.99 (0.68, 5.87) .209
T3 128 (12.38%) 3.32 (1.86, 5.92) <.001 61 (10.65%) 2.54 (0.91, 7.13) .076
T4a 591 (57.16%) 4.93 (2.88, 8.43) <.001 384 (67.02%) 3.66 (1.36, 9.82) .010
T4b 137 (13.25%) 9.13 (5.23, 15.96) <.001 73 (12.74%) 5.53 (2.01, 15.22) .001
Lymph node metastasis
N0 243 (23.50%) 1.00 (Ref.) 110 (19.20%) 1.00 (Ref.)
N1 187 (18.09%) 1.35 (0.99, 1.85) .056 96 (16.75%) 1.06 (0.71, 1.59) .772
N2 226 (21.86%) 2.44 (1.86, 3.20) <.001 149 (26.00%) 1.86 (1.33, 2.61) <.001
N3a 244 (23.60%) 4.69 (3.62, 6.08) <.001 153 (26.70%) 3.46 (2.49, 4.80) <.001
N3b 134 (12.96%) 9.24 (6.96, 12.27) <.001 65 (11.34%) 7.81 (5.33, 11.46) <.001
TD
Negative 794 (76.79%) 1.00 (Ref.) 382 (66.67%) 1.00 (Ref.)
Positive 240 (23.21%) 1.75 (1.47, 2.08) <.001 191 (33.33%) 1.28 (1.04, 1.58) .019

Data are presented as mean ± SD or n (%).

Abbreviations: Ref, reference; SD, standard deviation; TD, tumor deposit.